Page last updated: 2024-12-07

n-(4-(2-benzimidazolyl)phenyl)maleimide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID117909
SCHEMBL ID179732
MeSH IDM0040317

Synonyms (28)

Synonym
n-[4-(2-benzimidazolyl)phenyl]maleimide, bioreagent, suitable for fluorescence, >=98.0% (hplc)
B1149
n-[4-(2-benzimidazolyl)phenyl]maleimide
27030-97-3
n-(4-(2-benzimidazolyl)phenyl)maleimide
1-[4-(1h-benzimidazol-2-yl)phenyl]pyrrole-2,5-dione
1h-pyrrole-2,5-dione, 1-(4-(1h-benzimidazol-2-yl)phenyl)-
n-(p-(2-benzimidazolyl)phenyl)maleimide
unii-464u78g56e
464u78g56e ,
einecs 248-173-3
1-(4-(1h-benzimidazol-2-yl)phenyl)-1h-pyrrole-2,5-dione
1h-pyrrole-2,5-dione, 1-[4-(1h-benzimidazol-2-yl)phenyl]-
AKOS015854281
SCHEMBL179732
DTXSID4067274
1070424-33-7
mfcd00042767
AS-70792
1-[4-(1h-1,3-benzodiazol-2-yl)phenyl]-2,5-dihydro-1h-pyrrole-2,5-dione
FT-0706059
1-(4-(1h-benzo[d]imidazol-2-yl)phenyl)-1h-pyrrole-2,5-dione
Q27258895
D88760
A919448
CBA03097
CS-0323823
HY-W278706
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (59.09)18.7374
1990's7 (31.82)18.2507
2000's2 (9.09)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.96

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.96 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index4.09 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.96)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other22 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]